Reply To: “Therapeutic Drug Monitoring for Sofosbuvir and Daclatasvir in Transplant Recipients With Chronic Hepatitis C and Advanced Renal Disease”
Journal of Hepatology - Netherlands
doi 10.1016/j.jhep.2016.07.019
Full Text
Open PDFAbstract
Available in full text
Categories
Date
November 1, 2016
Authors
Publisher
Elsevier BV